Citation
|
Title
|
DOI
|
Mention to respiratory disease except from asthma
|
Number (%) respiratory disease except from asthma
|
Mention to asthma
|
Number (%) asthma patients
|
Number of COVID-19 patients
|
Alkundi A, et al.
|
Clinical characteristics and outcomes of COVID-19 hospitalized patients with diabetes in the United Kingdom: A retrospective single centre study
|
10.1016/j.diabres.2020.108263
|
Yes
|
COPD: 7 (7.3%)
|
Yes
|
6 (2.6%)
|
232
|
Alsofayan YM, et al.
|
Clinical characteristics of COVID-19 in Saudi Arabia: A national retrospective study
|
10.1016/j.jiph.2020.05.026
|
Yes
|
Chronic lung disease: 57 (5.2%)
|
Yes
|
54 (4.9%)
|
1519
|
Aretz M, et al.
|
Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State
|
10.1001/jama.2020.4326
|
Yes
|
COPD: 7 (33.3%)
|
Yes
|
2 (9.1%)
|
21
|
Asghar MS, et al.
|
Clinical Profiles, Characteristics, and Outcomes of the First 100 Admitted COVID-19 Patients in Pakistan: A Single-Center Retrospective Study in a Tertiary Care Hospital of Karachi
|
10.7759/cureus.8712
|
Yes
|
COPD: 3 (3%)
|
Yes
|
2 (2%)
|
100
|
Benger M, et al.
|
Intracerebral haemorrhage and COVID-19: Clinical characteristics from a case series
|
10.1016/j.bbi.2020.06.005
|
No
|
-
|
Yes
|
1 (20%)
|
5
|
Bhatraju PK, et al.
|
Covid-19 in Critically Ill Patients in the Seattle Region — Case Series
|
10.1056/NEJMoa2004500
|
Yes
|
COPD: 1 (4%)
|
Yes
|
3 (12.5%)
|
24
|
Chao JY, et al
|
Clinical Characteristics and Outcomes of Hospitalized and Critically Ill Children and Adolescents with Coronavirus Disease 2019 (COVID-19) at a Tertiary Care Medical Center in New York City
|
10.1016/j.jpeds.2020.05.006
|
No
|
-
|
Yes
|
11 (24.4%)
|
46
|
Cheng FY, et al.
|
Using Machine Learning to Predict ICU Transfer in Hospitalized COVID-19 Patients
|
10.3390/jcm9061668
|
Yes
|
COPD: 219 (8.42%)
|
Yes
|
219 (8.42%)
|
2599
|
Cheung ZB & Forsh DA
|
Early outcomes after hip fracture surgery in COVID-19 patients in New York City
|
10.1016/j.jor.2020.06.003
|
Yes
|
COPD: 1 (10%)
|
Yes
|
2 (20%)
|
10
|
Chhiba KD, et al.
|
Prevalence and characterization of asthma in hospitalized and nonhospitalized patients with COVID-19
|
10.1016/j.jaci.2020.06.010
|
Yes
|
COPD: 111 (7,27%)
|
Yes
|
220 (14.2%)
|
1542
|
D'Silva KM, et al.
|
Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US 'hot spot'
|
10.1136/annrheumdis-2020-217888
|
Yes
|
COPD: 9 (5.7%)
|
Yes
|
31 (19.8%)
|
156
|
Du H, et al.
|
Clinical characteristics of 182 pediatric COVID-19 patients with different severities and allergic status
|
10.1111/all.14452
|
No
|
-
|
Yes
|
1 (2.3%)
|
43
|
Duanmu Y, et al.
|
Characteristics of Emergency Department Patients With COVID-19 at a Single Site in Northern California: Clinical Observations and Public Health Implications
|
10.1111/acem.14003
|
Yes
|
COPD: 1 (10%)
|
Yes
|
10 (10%)
|
100
|
Fan J, et al.
|
The epidemiology of reverse transmission of COVID-19 in Gansu Province, China.
|
10.1016/j.tmaid.2020.101741
|
Yes
|
COPD: N/A
|
Yes
|
N/A
|
37
|
Fernandéz R, et al.
|
COVID-19 in Solid Organ Transplant Recipients: A Single-Center Case Series from Spain
|
10.1111/ajt.15929
|
No
|
-
|
Yes
|
1 (5.55%)
|
18
|
Gayam V, et al.
|
Presenting characteristics, comorbidities, and outcomes of patients coinfected with COVID-19 and Mycoplasma pneumoniae in the USA
|
10.1002/jmv.26026
|
No
|
-
|
Yes
|
2 (33.3%)
|
6
|
Gold JAW, et al.
|
Characteristics and Clinical Outcomes of Adult Patients Hospitalized With COVID-19 - Georgia, March 2020
|
10.15585/mmwr.mm6918e1
|
Yes
|
COPD: 16 (5.2%)
|
Yes
|
32 (10.5%)
|
305
|
Goyal P, et al.
|
Clinical Characteristics of Covid-19 in New York City
|
10.1056/NEJMc2010419
|
Yes
|
COPD: 20 (5.1%)
|
Yes
|
49 (12.5%)
|
393
|
Huang D, et al.
|
A novel risk score to predict diagnosis with coronavirus disease 2019 (COVID-19) in suspected patients: A retrospective, multicenter, and observational study
|
10.1002/jmv.26143
|
Yes
|
COPD: 9 (2.7%)
|
Yes
|
5 (1.5%)
|
336
|
Jehi L, et al.
|
Individualizing Risk Prediction for Positive Coronavirus Disease 2019 Testing: Results From 11,672 Patients
|
10.1016/j.chest.2020.05.580
|
Yes
|
COPD/emphysema: 14 (1.26%)
|
Yes
|
163 (14.7%)
|
1108
|
Kaushik S, et al.
|
Multisystem Inflammatory Syndrome in Children Associated with Severe Acute Respiratory Syndrome Coronavirus 2 Infection (MIS-C): A Multi-institutional Study from New York City
|
10.1016/j.jpeds.2020.06.045
|
No
|
-
|
Yes
|
5 (15%)
|
33
|
Knight M, et al.
|
Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population-based cohort study
|
10.1136/bmj.m2107
|
No
|
-
|
Yes
|
31 (7%)
|
427
|
Korkmaz MF, et al.
|
The Epidemiological and Clinical Characteristics of 81 Children with COVID-19 in a Pandemic Hospital in Turkey: an Observational Cohort Study
|
10.3346/jkms.2020.35.e236
|
No
|
-
|
Yes
|
1 (1,23%)
|
81
|
Lechien JR, et al. 2020
|
Clinical and Epidemiological Characteristics of 1,420 European Patients With Mild-To-Moderate Coronavirus Disease 2019
|
10.1111/joim.13089
|
Yes
|
Respiratory insufficiency: 10 (0.7%)
|
Yes
|
93 (6.5%)
|
1420
|
Li X, et al. 2020
|
Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan
|
10.1016/j.jaci.2020.04.006
|
Yes
|
COPD: 17 (3.1%)
|
Yes
|
5 (0.9%)
|
548
|
Liabeuf S, et al.
|
Association between renin-angiotensin system inhibitors and COVID-19 complications
|
10.1093/ehjcvp/pvaa062
|
Yes
|
COPD: 26 (10%)
|
Yes
|
14 (5%)
|
268
|
Liu BM, et al.
|
Epidemiological characteristics of COVID-19 patients in convalescence period
|
10.1017/S0950268820001181
|
Yes
|
Pulmonary tuberculosis: 4 (5.9%)
|
Yes
|
1 (1.5%)
|
68
|
Liu D, et al.
|
The pulmonary sequalae in discharged patients with COVID-19: a short-term observational study
|
10.1186/s12931-020-01385-1
|
No
|
-
|
Yes
|
4 (2.8%)
|
149
|
Lokken EM, et al.
|
Clinical characteristics of 46 pregnant women with a severe acute respiratory syndrome coronavirus 2 infection in Washington State
|
10.1016/j.ajog.2020.05.031
|
No
|
-
|
Yes
|
4 (8.7%)
|
46
|
Magagnoli et al.
|
Outcomes of Hydroxychloroquine Usage in United States Veterans Hospitalized with COVID-19
|
10.1016/j.medj.2020.06.001
|
Yes
|
COPD: 175 (21.68%)
|
Yes
|
40 (4.95%)
|
807
|
Mestre-Goméz B, et al.
|
Incidence of pulmonary embolism in non‑critically ill COVID‑19 patients. Predicting factors for a challenging diagnosis
|
10.1007/s11239-020-02190-9
|
Yes
|
Chronic obstrutive lung disease: 13 (14.28%)
|
Yes
|
7 (7.69%)
|
91
|
Mikami T, et al.
|
Risk Factors for Mortality in Patients with COVID-19 in New York City.
|
10.1007/s11606-020-05983-z
|
Yes
|
COPD: 176 (2.7%)
|
Yes
|
271 (4.2%)
|
6493
|
Mitra AR, et al.
|
Baseline characteristics and outcomes of patients with COVID-19 admitted to intensive care units in Vancouver, Canada: a case series
|
10.1503/cmaj.200794
|
Yes
|
COPD: 8 (6.8%)
|
Yes
|
14 (12%)
|
117
|
Oualha M, et al.
|
Severe and fatal forms of COVID-19 in children
|
10.1016/j.arcped.2020.05.010
|
Yes
|
COPD: 1 (3.7%) e Chronic lung disease: 2 (7.4%)
|
Yes
|
1 (3,7%)
|
27
|
Pare JR, et al.
|
Point-of-care Lung Ultrasound Is More Sensitive than Chest Radiograph for Evaluation of COVID-19
|
10.5811/westjem.2020.5.47743
|
Yes
|
COPD: 1 (3.7%)
|
Yes
|
4 (14.8%)
|
27
|
Peyrony O, et al.
|
Accuracy of Emergency Department Clinical Findings for Diagnosis of Coronavirus Disease 2019
|
10.1016/j.annemergmed.2020.05.022
|
Yes
|
COPD: 24 (6.2%)
|
Yes
|
22 (5.7%)
|
391
|
Phipps MM, et al.
|
Acute Liver Injury in COVID-19: Prevalence and Association with Clinical Outcomes in a Large US Cohort
|
10.1002/hep.31404
|
Yes
|
COPD: 185 (8.1%)
|
Yes
|
308 (14)
|
2273
|
Pongpirul WA, et al.
|
Clinical Characteristics of Patients Hospitalized with Coronavirus Disease, Thailand
|
10.3201/eid2607.200598
|
Yes
|
COPD: 0
|
Yes
|
0
|
11
|
Price-Haywood EG, et al.
|
Hospitalization and Mortality among Black Patients and White Patients with Covid-19
|
10.1056/NEJMsa2011686
|
Yes
|
COPD: 79 (2.25%)
|
Yes
|
147 (4%)
|
3481
|
Richardson S, et al.
|
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.
|
10.1001/jama.2020.6775
|
Yes
|
COPD: 287 (5.4%)
|
Yes
|
479 (9%)
|
5700
|
San-Juan R, et al.
|
Incidence and clinical profiles of COVID-19 pneumonia in pregnant women: A single-centre cohort study from Spain
|
10.1016/j.eclinm.2020.100407
|
No
|
-
|
Yes
|
4 (12.5%)
|
32
|
Satici C, et al.
|
Performance of pneumonia severity index and CURB-65 in predicting 30-day mortality in patients with COVID-19
|
10.1016/j.ijid.2020.06.038
|
Yes
|
COPD: 28 (4.1%)
|
Yes
|
43 (6.3%)
|
681
|
Sentilhes L, et al.
|
Coronavirus disease 2019 in pregnancy was associated with maternal morbidity and preterm birth
|
10.1016/j.ajog.2020.06.022
|
No
|
-
|
Yes
|
5 (9.3%)
|
54
|
Shahriarirad R, et al.
|
Epidemiological and clinical features of 2019 novel coronavirus diseases (COVID-19) in the South of Iran
|
10.1186/s12879-020-05128-x
|
Yes
|
COPD: 9 (8%)
|
Yes
|
7 (6.2%)
|
113
|
Smith SM, et al.
|
Impaired glucose metabolism in patients with diabetes, prediabetes and obesity is associated with severe Covid-19
|
10.1002/jmv.26227
|
Yes
|
COPD: 12 (6.5%)
|
Yes
|
18 (9.8%)
|
184
|
Solís & Carreňo
|
COVID-19 Fatality and Comorbidity Risk Factors among Diagnosed Patients in Mexico
|
10.1101/2020.04.21.20074591
|
Yes
|
COPD: 202 (2.7%)
|
Yes
|
270 (3.6%)
|
7497
|
Sultan I, et al.
|
The Role of Extracorporeal Life Support for Patients With COVID-19: Preliminary Results from a Statewide Experience
|
10.1111/jocs.14583
|
No
|
-
|
Yes
|
N/A
|
10
|
Wang X, et al.
|
Nosocomial Outbreak of 2019 Novel Coronavirus Pneumonia in Wuhan, China
|
10.1183/13993003.00544-2020
|
No
|
-
|
Yes
|
2 (5.7%)
|
35
|
Zhang C, et al.
|
Clinical and epidemiological characteristics of pediatric SARS-CoV-2 infections in China: A multicenter case series
|
10.1371/journal.pmed.1003130
|
No
|
-
|
Yes
|
1 (3%)
|
34
|
Zhang JJ, et al.
|
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China
|
10.1111/all.14238
|
Yes
|
COPD: 2 (1.4%)
|
Yes
|
0
|
140
|
Zhao M, et al.
|
Comparison of clinical characteristics and outcomes of patients with coronavirus disease 2019 at different ages
|
10.18632/aging.103298
|
Yes
|
COPD: 23 (2.3%)
|
Yes
|
12 (1.2%)
|
1000
|
Zhou X, et al.
|
Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) Patients with Hypertension on Renin-Angiotensin System Inhibitors
|
10.1080/10641963.2020.1764018
|
Yes
|
COPD:3 (2.7%)
|
Yes
|
1 (0.9%)
|
110
|